Endothelial Protection
Supports a protective coating over the corneal endothelium, helping reduce mechanical and ultrasonic stress during phacoemulsification.
Premium OVD
Sodium Hyaluronate
1 ml PFS
SODIUM HYALURONATE OPHTHALMIC SOLUTION
PURE-HYAL 1.4%
High-purity sodium hyaluronate viscoelastic engineered to protect the corneal endothelium, maintain anterior chamber stability, and support precise intraocular manipulation in cataract and anterior segment surgery.
Designed for
Chamber stability
Focus
Endothelial protection
Format
Sterile, single-use
PURE-HYAL
1.4%
PURE-HYAL 1.4% is positioned as Agaaz Ophthalmics’ premium sodium hyaluronate solution — tuned for consistent performance, clean visibility, and dependable tissue protection throughout the procedure.
Stable Anterior Chamber
Helps maintain space and clarity during critical steps such as capsulorhexis, lens implantation, and IOL positioning.
Predictable Handling
Designed for smooth injection and efficient removal — supporting surgical rhythm without unnecessary resistance.
At a glance
A surgeon-friendly view of the essentials — built for fast scanning and confident selection.
1.4%
Conc.
Sodium Hyaluronate
Premium viscoelastic profile
1 ml
PFS
Prefilled syringe
Procedure-ready, single-use
Sterile
Use
Single-use format
Clear handling pathway
OVD
Type
Anterior segment
Cataract workflow aligned
Technical specifications
BrandPURE-HYAL
Product typeOVD / Viscoelastic
Active ingredientSodium Hyaluronate
Concentration1.4%
Presentation1 ml Prefilled Syringe (PFS)
SterilitySterile, single-use
Use caseCataract & anterior segment surgery
SupportDocumentation support available
Clinical positioning
PURE-HYAL 1.4% is suited for surgeons seeking a sodium hyaluronate viscoelastic that combines space maintenance with dependable endothelial protection. It integrates cleanly into modern cataract workflows and supports consistent outcomes across a wide patient spectrum.
What surgeons notice
Clarity, stability, predictable removal
Where it fits
Capsulorhexis to IOL placement
Start with PURE-HYAL 1.4%
Share your market and expected volumes. We’ll support you with product details, documentation, and a clear path to get started.
Premium OVD
Sodium Hyaluronate
1 ml PFS
SODIUM HYALURONATE OPHTHALMIC SOLUTION
PURE-HYAL 1.4%
High-purity sodium hyaluronate viscoelastic engineered to protect the corneal endothelium, maintain anterior chamber stability, and support precise intraocular manipulation in cataract and anterior segment surgery.
Designed for
Chamber stability
Focus
Endothelial protection
Format
Sterile, single-use
PURE-HYAL
1.4%
PURE-HYAL 1.4% is positioned as Agaaz Ophthalmics’ premium sodium hyaluronate solution — tuned for consistent performance, clean visibility, and dependable tissue protection throughout the procedure.
Endothelial Protection
Supports a protective coating over the corneal endothelium, helping reduce mechanical and ultrasonic stress during phacoemulsification.
Stable Anterior Chamber
Helps maintain space and clarity during critical steps such as capsulorhexis, lens implantation, and IOL positioning.
Predictable Handling
Designed for smooth injection and efficient removal — supporting surgical rhythm without unnecessary resistance.
At a glance
A surgeon-friendly view of the essentials — built for fast scanning and confident selection.
1.4%
Conc.
Sodium Hyaluronate
Premium viscoelastic profile
1 ml
PFS
Prefilled syringe
Procedure-ready, single-use
Sterile
Use
Single-use format
Clear handling pathway
OVD
Type
Anterior segment
Cataract workflow aligned
Technical specifications
BrandPURE-HYAL
Product typeOVD / Viscoelastic
Active ingredientSodium Hyaluronate
Concentration1.4%
Presentation1 ml Prefilled Syringe (PFS)
SterilitySterile, single-use
Use caseCataract & anterior segment surgery
SupportDocumentation support available
Clinical positioning
PURE-HYAL 1.4% is suited for surgeons seeking a sodium hyaluronate viscoelastic that combines space maintenance with dependable endothelial protection. It integrates cleanly into modern cataract workflows and supports consistent outcomes across a wide patient spectrum.
What surgeons notice
Clarity, stability, predictable removal
Where it fits
Capsulorhexis to IOL placement
Start with PURE-HYAL 1.4%
Share your market and expected volumes. We’ll support you with product details, documentation, and a clear path to get started.